About UCSF Search UCSF UCSF Medical Center

Norah Terrault, MD, MPH

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
terrault_norah

Assistant Professor, Department of Medicine (Gastroenterology), UCSF

Phone: (415) 353-2318 (appts)
Box 0538, UCSF
San Francisco, CA 94143-0538

View on UCSF Profiles


Additional Websites


Education

University of Alberta, MD, 1984-87
University of Toronto, FRCPC, 1988-92, Internal Medicine
University of Toronto, FRCPC, 1992-94, Gastroenterology
University of California, Berkeley, MPH, 1996-97, Epidemiology

Professional Experience

  • 1987-88 Comprehensive internship, University of Toronto
  • 1988-91
    Residency in Internal Medicine, University of Toronto
  • 1991-93
    Residency in Gastroenterology, University of Toronto
  • 1993-94
    Clinical Fellowship, University of Toronto
  • 1994-97
    Research Fellowship, University of California San Francisco
  • 1997-2002
    Adjunct Assistant Professor, Dept. of Medicine/Gastroenterology, University of California San Francisco
  • 2002-present
    Assistant Professor, Dept. of Medicine/Gastroenterology, University of California San Francisco

Honors & Awards

  • 1991
    Dr. D.H. Cowan, University of Toronto Teaching Award
  • 1992
    CAG Residents' Presentation Award
  • 1994
    CASL Presentation Award
  • 1994-96
    Canadian Liver Foundation Fellowship Award
  • 1996
    Canadian Liver Foundation Fellowship Award (declined)
  • 1996
    Medical Research Council of Canada Fellowship Award (declined)
  • 1996-8
    Dr. Saul Krugman Career Development Award
  • 1997-9
    Jan Albrecht Career Development Award

Selected Publications

  1. Saxena V, Monto A, Terrault N. Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals - authors' reply. Aliment Pharmacol Ther. 2014 Jun; 39(12):1428.
    View on PubMed
  2. Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. J Viral Hepat. 2014 Aug; 21(8):e74-7.
    View on PubMed
  3. Saxena V, Manos MM, Yee HS, Catalli L, Wayne E, Murphy RC, Shvachko VA, Pauly MP, Chua J, Monto A, Terrault NA. Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis. Aliment Pharmacol Ther. 2014 May; 39(10):1213-24.
    View on PubMed
  4. Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P. Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients. Am J Transplant. 2014 May; 14(5):1129-35.
    View on PubMed
  5. Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: An extended observation study. Hepatology. 2014 Apr; 59(4):1311-9.
    View on PubMed
  6. Schwartz JB, Lai J, Lizaola B, Kane L, Markova S, Weyland P, Terrault NA, Stotland N, Bikle D. A Comparison of Measured and Calculated Free 25(OH) Vitamin D Levels in Clinical Populations. J Clin Endocrinol Metab. 2014 May; 99(5):1631-7.
    View on PubMed
  7. Hartigan-O'Connor DJ, Lin D, Ryan JC, Shvachko VA, Cozen ML, Segal MR, Terrault NA, Lanier LL, Manos MM, McCune JM. Monocyte Activation by Interferon a Is Associated With Failure to Achieve a Sustained Virologic Response After Treatment for Hepatitis C Virus Infection. J Infect Dis. 2014 May; 209(10):1602-12.
    View on PubMed
  8. Harbell J, Terrault NA, Stock P. Solid organ transplants in HIV-infected patients. Curr HIV/AIDS Rep. 2013 Sep; 10(3):217-25.
    View on PubMed
  9. Gordon SC, Hamzeh FM, Pockros PJ, Hoop RS, Buikema AR, Korner EJ, Terrault NA. Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease. Aliment Pharmacol Ther. 2013 Oct; 38(7):784-93.
    View on PubMed
  10. Shores NJ, Dodge JL, Feng S, Terrault NA. Donor Risk Index for African American liver transplant recipients with hepatitis C virus. Hepatology. 2013 Oct; 58(4):1263-9.
    View on PubMed
  11. Terrault N, Dodge J, Alter M. Reply. Hepatology. 2013 Sep; 58(3):1191.
    View on PubMed
  12. Freeman J, Emond J, Gillespie BW, Appelbaum PS, Weinrieb R, Hill-Callahan P, Gordon EJ, Terrault N, Trotter J, Ashworth A, Dew MA, Pruett T. Computerized assessment of competence-related abilities in living liver donors: the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Clin Transplant. 2013 Jul-Aug; 27(4):633-45.
    View on PubMed
  13. Marcellin P, Cooper C, Balart L, Larrey D, Box T, Yoshida E, Lawitz E, Buggisch P, Ferenci P, Weltman M, Labriola-Tompkins E, Le Pogam S, Nájera I, Thomas D, Hooper G, Shulman NS, Zhang Y, Navarro MT, Lim CY, Brunda M, Terrault NA, Yetzer ES. Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection. Gastroenterology. 2013 Oct; 145(4):790-800.e3.
    View on PubMed
  14. Terrault N. Prophylaxis in HBV-infected liver transplant patients: end of the HBIG era? Am J Gastroenterol. 2013 Jun; 108(6):949-51.
    View on PubMed
  15. Lucey MR, Terrault N. Reply. Liver Transpl. 2013 Jun; 19(6):672.
    View on PubMed
  16. Terrault NA, Dodge JL, Murphy EL, Tavis JE, Kiss A, Levin TR, Gish RG, Busch MP, Reingold AL, Alter MJ. Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology. 2013 Mar; 57(3):881-9.
    View on PubMed
  17. Everson GT, Terrault NA, Lok AS, Rodrigo del R, Brown RS, Saab S, Shiffman ML, Al-Osaimi AM, Kulik LM, Gillespie BW, Everhart JE. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation. Hepatology. 2013 May; 57(5):1752-62.
    View on PubMed
  18. Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, Teperman LW. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013 Jan; 19(1):3-26.
    View on PubMed
  19. Flemming JA, Terrault NA. Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection. Infect Dis Clin North Am. 2012 Dec; 26(4):903-15.
    View on PubMed
  20. Biggins SW, Bambha KM, Terrault NA, Inadomi J, Shiboski S, Dodge JL, Gralla J, Rosen HR, Roberts JP. Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma. Liver Transpl. 2012 Dec; 18(12):1471-8.
    View on PubMed

Go to UCSF Profiles, powered by CTSI